Long‐Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice
ABSTRACT Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). However, bone fragility has emerged as a side effect in some but not in all human studies. Because use of SGLT2 inhibitors in humans affects mineral...
| 出版年: | JBMR Plus |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Oxford University Press
2021-08-01
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/jbm4.10526 |